Stay updated on RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Sign up to get notified when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.

Latest updates to the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1, with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page now lists Revision: v3.3.1 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved the operating-status notice related to government funding and potential site downtime. The trial details and core content remain unchanged.SummaryDifference0.2%

- Check43 days agoChange DetectedNo significant content changes detected on the Study Details page; observed differences appear to be minor, non-substantive updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study locations were updated: Cali, Colombia was added and Santiago de Cali, Colombia was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedPage updates: version updated to v3.2.0 and new government-operating-status notice plus a new genetic disease resource added; old version v3.1.0 removed.SummaryDifference3%

Stay in the know with updates to RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.